326 related articles for article (PubMed ID: 26666581)
21. Modulation of B Cells and Homing Marker on NK Cells Through Extracorporeal Photopheresis in Patients With Steroid-Refractory/Resistant Graft-Vs.-Host Disease Without Hampering Anti-viral/Anti-leukemic Effects.
Wang L; Ni M; Hückelhoven-Krauss A; Sellner L; Hoffmann JM; Neuber B; Luft T; Hegenbart U; Schönland S; Kleist C; Sill M; Chen BA; Wuchter P; Eckstein V; Krüger W; Hilgendorf I; Yerushalmi R; Nagler A; Müller-Tidow C; Ho AD; Dreger P; Schmitt M; Schmitt A
Front Immunol; 2018; 9():2207. PubMed ID: 30349527
[TBL] [Abstract][Full Text] [Related]
22. Biomarker profile predicts clinical efficacy of extracorporeal photopheresis in steroid-resistant acute and chronic graft-vs-host disease after allogenic hematopoietic stem cell transplant.
Amat P; López-Corral L; Goterris R; Pérez A; López O; Heras I; Arbona C; Viguria MC; Hernández-Boluda JC; Martínez-Ruiz F; Martínez A; Solano C
J Clin Apher; 2021 Oct; 36(5):697-710. PubMed ID: 34185332
[TBL] [Abstract][Full Text] [Related]
23. Extracorporeal photopheresis for paediatric patients experiencing graft-versus-host disease (GVHD).
Rutella S; Valentini CG; Ceccarelli S; Romano MT; Brescia LP; Milano GM; Locatelli F
Transfus Apher Sci; 2014 Jun; 50(3):340-8. PubMed ID: 24780391
[TBL] [Abstract][Full Text] [Related]
24. Extracorporeal Photopheresis for Treatment of Acute and Chronic Graft Versus Host Disease: An Italian Multicentric Retrospective Analysis on 94 Patients on Behalf of the Gruppo Italiano Trapianto di Midollo Osseo.
Malagola M; Cancelli V; Skert C; Leali PF; Ferrari E; Tiburzi A; Sala ML; Donnini I; Chiusolo P; Mussetti A; Battista M; Turra A; Cattina F; Rambaldi B; Schieppati F; Polverelli N; Bernardi S; Perucca S; Marini M; Laszlo D; Savignano C; Patriarca F; Corradini P; Piccirillo N; Sica S; Bosi A; Russo D
Transplantation; 2016 Dec; 100(12):e147-e155. PubMed ID: 27861297
[TBL] [Abstract][Full Text] [Related]
25. Extracorporeal photopheresis: Is one ounce of blood enough? Case reports.
Kumukova I; Kurnikova E; Trakhtman P
Pediatr Blood Cancer; 2024 Mar; 71(3):e30800. PubMed ID: 38105463
[TBL] [Abstract][Full Text] [Related]
26. Extracorporeal Photopheresis in Graft-versus-Host Disease.
Asensi Cantó P; Sanz Caballer J; Solves Alcaína P; de la Rubia Comos J; Gómez Seguí I
Transplant Cell Ther; 2023 Sep; 29(9):556-566. PubMed ID: 37419324
[TBL] [Abstract][Full Text] [Related]
27. Extracorporeal photopheresis for graft-vs-host disease: A literature review and treatment guidelines proposed by the Nordic ECP Quality Group.
Nygaard M; Wichert S; Berlin G; Toss F
Eur J Haematol; 2020 May; 104(5):361-375. PubMed ID: 31908057
[TBL] [Abstract][Full Text] [Related]
28. An alternative for extracorporeal photopheresis: 8-methoxypsoralen and UVA-treated leucocytes from allogeneic donors improve graft-versus-host disease in mice.
Budde H; Papert S; Reichardt HM; Jarry H; Riggert J; Legler TJ
Vox Sang; 2018 Nov; 113(8):803-810. PubMed ID: 30353554
[TBL] [Abstract][Full Text] [Related]
29. Extracorporeal photopheresis: a useful therapy for patients with steroid-refractory acute graft-versus-host disease but not for the prevention of the chronic form.
Rubegni P; Feci L; Poggiali S; Marotta G; D'Ascenzo G; Murdaca F; Fimiani M
Br J Dermatol; 2013 Aug; 169(2):450-7. PubMed ID: 23534380
[TBL] [Abstract][Full Text] [Related]
30. First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia.
Peinemann F; Bartel C; Grouven U
Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD006407. PubMed ID: 23881658
[TBL] [Abstract][Full Text] [Related]
31. The role of the extracorporeal photopheresis in the management of the graft-versus-host disease.
Kaloyannidis P; Mallouri D
Transfus Apher Sci; 2012 Apr; 46(2):211-9. PubMed ID: 22123355
[TBL] [Abstract][Full Text] [Related]
32. Extracorporeal Photopheresis as Graft-versus-Host Disease Prophylaxis: A Randomized Controlled Trial.
Ali MM; Gedde-Dahl T; Osnes LT; Perrier F; Veierød MB; Tjønnfjord GE; Iversen PO
Transplant Cell Ther; 2023 Jun; 29(6):364.e1-364.e11. PubMed ID: 36878428
[TBL] [Abstract][Full Text] [Related]
33. Corticosteroids for preventing graft-versus-host disease after allogeneic myeloablative stem cell transplantation.
Quellmann S; Schwarzer G; Hübel K; Greb A; Engert A; Bohlius J
Cochrane Database Syst Rev; 2008 Jul; (3):CD004885. PubMed ID: 18646116
[TBL] [Abstract][Full Text] [Related]
34. Interventions for mycosis fungoides.
Valipour A; Jäger M; Wu P; Schmitt J; Bunch C; Weberschock T
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD008946. PubMed ID: 32632956
[TBL] [Abstract][Full Text] [Related]
35. Extracorporeal photopheresis in children with graft-versus-host disease.
Chan KW
J Clin Apher; 2006 Apr; 21(1):60-4. PubMed ID: 16619229
[TBL] [Abstract][Full Text] [Related]
36. Analysis of clinical outcome and survival in pediatric patients undergoing extracorporeal photopheresis for the treatment of steroid-refractory GVHD.
González Vicent M; Ramirez M; Sevilla J; Abad L; Díaz MA
J Pediatr Hematol Oncol; 2010 Nov; 32(8):589-93. PubMed ID: 20962677
[TBL] [Abstract][Full Text] [Related]
37. Extracorporeal photopheresis in the treatment of acute and chronic graft-versus-host disease: A position statement from the Turkish Society of Apheresis (TSA).
Kaynar L; Tekgunduz E; Kozanoglu I; Ozkan HA; Aksu S; Ozkalemkas F; Demirkan F
Transfus Apher Sci; 2022 Feb; 61(1):103373. PubMed ID: 35123893
[TBL] [Abstract][Full Text] [Related]
38. Extracorporeal photopheresis with TC-V in Japanese patients with steroid-resistant chronic graft-versus-host disease.
Okamoto S; Teshima T; Kosugi-Kanaya M; Kahata K; Kawashima N; Kato J; Mori T; Ozawa Y; Miyamura K
Int J Hematol; 2018 Sep; 108(3):298-305. PubMed ID: 29959747
[TBL] [Abstract][Full Text] [Related]
39. Long-term extracorporeal photochemotherapy in a pediatric patient with refractory sclerodermatous chronic graft-versus-host disease.
Bisaccia E; Palangio M; Gonzalez J
Transfus Apher Sci; 2011 Oct; 45(2):187-90. PubMed ID: 21890415
[TBL] [Abstract][Full Text] [Related]
40. Extracorporeal photopheresis performed on the CELLEX® compared with the UVAR-XTS® instrument is more efficient and better tolerated in children with steroid-refractory graft-versus-host disease.
Kapadia E; Wong E; Perez-Albuerne E; Jacobsohn D
Pediatr Blood Cancer; 2015 Aug; 62(8):1485-8. PubMed ID: 25881179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
